Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$646.4K
2 trades · 1 insiders
Net · 90d
$-646.4K
Insiders on file
34
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Dodd Sheri Louise | Director | 18 | $0 | $1.52M | 2026-08-10 |
| Birkemeyer Elaine M. | Chief Financial Officer | 18 | $0 | $648.6K | 2026-05-11 |
| King Laura G. | Director | 3 | $0 | $0 | 2026-05-06 |
| Washington Boyd Vindell | Director | 4 | $0 | $0 | 2026-05-06 |
| Asbury Valerie L. | Director | 6 | $0 | $0 | 2026-05-06 |
| Shafer David Brent | Director | 6 | $0 | $0 | 2026-05-06 |
| Huggenberger Raymond | Director | 12 | $0 | $0 | 2026-05-06 |
| Pearson Andrea | Director | 2 | $0 | $0 | 2026-05-06 |
| Volkart Carmen B | Director | 5 | $0 | $0 | 2026-05-06 |
| BURKE WILLIAM W | Director | 41 | $44.8K | $1.73M | 2026-05-06 |
| Burns Kristie | Sr. VP Mktg & Clinical Affairs | 31 | $0 | $779.2K | 2026-02-24 |
| REUVERS DANIEL L. | President and CEO | 28 | $0 | $1.18M | 2025-03-11 |
| Ferstler Sherri Lee | Senior VP, Sales | 3 | $0 | $20.3K | 2024-08-12 |
| PAULS ERIC | Senior VP, Sales | 10 | $0 | $40.5K | 2023-05-08 |
| Moen Brent | Chief Financial Officer | 26 | $48.8K | $220.4K | 2023-03-01 |
| Jain Deepti | Director | 3 | $0 | $0 | 2022-05-09 |
| ROCHE KEVIN H | Director | 34 | $0 | $6.36M | 2021-10-01 |
| NIGON RICHARD | Director | 42 | $718.5K | $1.34M | 2021-05-17 |
| SODERBERG PETER H | Director | 24 | $1.00M | $0 | 2021-05-17 |
| Rishe Bryan | Vice President, Sales | 134 | $0 | $8.53M | 2021-03-05 |
| Pegus Cheryl | Director | 11 | $27.9K | $0 | 2020-05-04 |
| Mattys Gerald R. | Chief Executive Officer | 114 | $0 | $22.04M | 2020-04-29 |
| Folkes Robert J. | Chief Operating Officer | 194 | $0 | $10.41M | 2020-03-05 |
| Thompson Maggie | VP Payer Rltns & Govt Affr | 61 | $0 | $5.62M | 2019-05-10 |
| Blake Lynn Larson | Chief Financial Officer | 22 | $0 | $490.6K | 2018-08-16 |
| Davis Jordan | Director | 29 | $0 | $38.68M | 2018-02-27 |
| Galen Management, LLC | 10% Owner | 1 | $0 | $86.69M | 2017-09-15 |
| Radius Venture Partners III, LLC | 10% Owner | 3 | $0 | $31.04M | 2017-09-15 |
| Galen Partners V LP | 10% Owner | 3 | $0 | $15.35M | 2017-06-28 |
| Anderson Mary E. | Vice President, Reimbursement | 38 | $0 | $2.26M | 2017-06-05 |
| Galen Partners V, L.L.C. | 10% Owner | 7 | $0 | $18.81M | 2017-06-01 |
| SHROFF ZUBEEN | Director | 10 | $0 | $0 | 2017-05-09 |
| SHAPIRO STEPHEN I | Director | 6 | $0 | $150.6K | 2017-03-02 |
| LUBIN DANIEL C | 10% Owner | 6 | $0 | $0 | 2016-08-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Dodd Sheri Louise | Chief Executive Officer | S Sale | 2026-08-10 | 2026-08-12 | 10,978 | $29.44 | $323.2K | 232,907 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer, Dir | S Sale | 2026-08-10 | 2026-08-12 | 10,978 | $29.44 | $323.2K | 232,907 | SEC↗ |
| Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | S Sale | 2026-05-11 | 2026-05-13 | 4,631 | $24.49 | $113.4K | 130,188 | SEC↗ |
| BURKE WILLIAM W | Director | A Award | 2026-05-06 | 2026-05-08 | 6,521 | — | $0 | 55,041 | SEC↗ |
| Washington Boyd Vindell | Director | A Award | 2026-05-06 | 2026-05-08 | 6,521 | — | $0 | 41,768 | SEC↗ |
| Volkart Carmen B | Director | A Award | 2026-05-06 | 2026-05-08 | 6,521 | — | $0 | 44,219 | SEC↗ |
| Shafer David Brent | Director | A Award | 2026-05-06 | 2026-05-08 | 6,521 | — | $0 | 55,343 | SEC↗ |
| Pearson Andrea | Director | A Award | 2026-05-06 | 2026-05-08 | 6,521 | — | $0 | 7,373 | SEC↗ |
| King Laura G. | Director | A Award | 2026-05-06 | 2026-05-08 | 6,521 | — | $0 | 25,569 | SEC↗ |
| Huggenberger Raymond | Director | A Award | 2026-05-06 | 2026-05-08 | 6,521 | — | $0 | 62,841 | SEC↗ |
| Asbury Valerie L. | Director | A Award | 2026-05-06 | 2026-05-08 | 6,521 | — | $0 | 55,343 | SEC↗ |
| Pearson Andrea | Director | A Award | 2026-03-09 | 2026-03-11 | 852 | — | $0 | 852 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2026-02-24 | 2026-02-26 | 6,246 | $28.94 | $180.8K | 82,581 | SEC↗ |
| Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | S Sale | 2026-02-24 | 2026-02-26 | 7,701 | $28.94 | $222.9K | 134,819 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | S Sale | 2026-02-24 | 2026-02-26 | 10,993 | $28.94 | $318.1K | 243,885 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2026-02-23 | 2026-02-24 | 160 | $28.69 | $4.6K | 88,827 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2026-02-23 | 2026-02-24 | 4,279 | $28.28 | $121.0K | 88,987 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | S Sale | 2026-02-23 | 2026-02-24 | 537 | $28.69 | $15.4K | 254,878 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | S Sale | 2026-02-23 | 2026-02-24 | 14,703 | $28.28 | $415.8K | 255,415 | SEC↗ |
| Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | S Sale | 2026-02-23 | 2026-02-24 | 196 | $28.69 | $5.6K | 142,520 | SEC↗ |
| Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | S Sale | 2026-02-23 | 2026-02-24 | 5,322 | $28.28 | $150.5K | 142,716 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2026-02-20 | 2026-02-24 | 3,490 | — | $0 | 82,085 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2026-02-20 | 2026-02-24 | 4,058 | — | $0 | 86,143 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2026-02-20 | 2026-02-24 | 7,123 | — | $0 | 93,266 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | A Award | 2026-02-20 | 2026-02-24 | 19,751 | — | $0 | 241,902 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | A Award | 2026-02-20 | 2026-02-24 | 28,216 | — | $0 | 270,118 | SEC↗ |
| Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | A Award | 2026-02-20 | 2026-02-24 | 15,575 | — | $0 | 148,038 | SEC↗ |
| Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | A Award | 2026-02-20 | 2026-02-24 | 6,765 | — | $0 | 132,463 | SEC↗ |
| Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | A Award | 2026-02-20 | 2026-02-24 | 3,579 | — | $0 | 125,698 | SEC↗ |
| Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | A Award | 2026-02-19 | 2026-02-23 | 23,008 | — | $0 | 122,119 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2026-02-19 | 2026-02-23 | 6,194 | — | $0 | 78,595 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | A Award | 2026-02-19 | 2026-02-23 | 48,672 | — | $0 | 222,151 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2026-01-02 | 2026-01-06 | 5,139 | $28.85 | $148.3K | 72,401 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | S Sale | 2025-08-08 | 2025-08-12 | 7,762 | $12.36 | $95.9K | 173,479 | SEC↗ |
| Birkemeyer Elaine M. | Chief Financial Officer | S Sale | 2025-05-12 | 2025-05-14 | 2,921 | $9.94 | $29.0K | 99,111 | SEC↗ |
| BURKE WILLIAM W | Director | S Sale | 2025-05-08 | 2025-05-09 | 3,300 | $9.67 | $31.9K | 48,520 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | S Sale | 2025-05-08 | 2025-05-12 | 3,149 | $9.83 | $31.0K | 181,241 | SEC↗ |
| Washington Boyd Vindell | Director | A Award | 2025-05-07 | 2025-05-09 | 16,078 | — | $0 | 35,247 | SEC↗ |
| Volkart Carmen B | Director | A Award | 2025-05-07 | 2025-05-09 | 16,078 | — | $0 | 37,698 | SEC↗ |
| Shafer David Brent | Director | A Award | 2025-05-07 | 2025-05-09 | 16,078 | — | $0 | 48,822 | SEC↗ |
| King Laura G. | Director | A Award | 2025-05-07 | 2025-05-09 | 16,078 | — | $0 | 19,048 | SEC↗ |
| Huggenberger Raymond | Director | A Award | 2025-05-07 | 2025-05-09 | 16,078 | — | $0 | 56,320 | SEC↗ |
| Asbury Valerie L. | Director | A Award | 2025-05-07 | 2025-05-09 | 16,078 | — | $0 | 48,822 | SEC↗ |
| BURKE WILLIAM W | Director | A Award | 2025-05-07 | 2025-05-09 | 16,078 | — | $0 | 51,820 | SEC↗ |
| REUVERS DANIEL L. | Director | G Gift | 2025-03-11 | 2025-03-13 | 68,162 | — | $0 | 146,442 | SEC↗ |
| REUVERS DANIEL L. | Director | G Gift | 2025-03-11 | 2025-03-13 | 68,162 | — | $0 | 68,162 | SEC↗ |
| REUVERS DANIEL L. | Director | S Sale | 2025-02-25 | 2025-02-27 | 28,338 | $14.18 | $401.8K | 214,604 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2025-02-25 | 2025-02-27 | 6,468 | $14.40 | $93.1K | 77,540 | SEC↗ |
| Birkemeyer Elaine M. | Chief Financial Officer | S Sale | 2025-02-25 | 2025-02-27 | 2,066 | $14.51 | $30.0K | 102,032 | SEC↗ |
| Birkemeyer Elaine M. | Chief Financial Officer | S Sale | 2025-02-24 | 2025-02-24 | 3,778 | $14.70 | $55.5K | 104,098 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2025-02-24 | 2025-02-24 | 4,830 | $14.65 | $70.8K | 84,008 | SEC↗ |
| REUVERS DANIEL L. | Director | S Sale | 2025-02-24 | 2025-02-24 | 10,938 | $14.55 | $159.1K | 242,942 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | A Award | 2025-02-20 | 2025-02-24 | 65,669 | — | $0 | 184,390 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | A Award | 2025-02-20 | 2025-02-24 | 20,108 | — | $0 | 118,721 | SEC↗ |
| King Laura G. | Director | A Award | 2025-02-20 | 2025-02-24 | 2,970 | — | $0 | 2,970 | SEC↗ |
| Birkemeyer Elaine M. | Chief Financial Officer | A Award | 2025-02-20 | 2025-02-24 | 6,887 | — | $0 | 71,628 | SEC↗ |
| Birkemeyer Elaine M. | Chief Financial Officer | A Award | 2025-02-20 | 2025-02-24 | 3,446 | — | $0 | 64,741 | SEC↗ |
| Birkemeyer Elaine M. | Chief Financial Officer | A Award | 2025-02-20 | 2025-02-24 | 36,248 | — | $0 | 107,876 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2025-02-20 | 2025-02-24 | 4,131 | — | $0 | 72,259 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2025-02-20 | 2025-02-24 | 3,359 | — | $0 | 68,128 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2025-02-20 | 2025-02-24 | 16,579 | — | $0 | 88,838 | SEC↗ |
| REUVERS DANIEL L. | Director | A Award | 2025-02-20 | 2025-02-24 | 15,853 | — | $0 | 253,880 | SEC↗ |
| Ferstler Sherri Lee | Senior VP, Sales | S Sale | 2024-08-12 | 2024-08-14 | 1,550 | $13.07 | $20.3K | 38,764 | SEC↗ |
| Dodd Sheri Louise | Chief Executive Officer | A Award | 2024-08-07 | 2024-08-09 | 64,959 | — | $0 | 98,613 | SEC↗ |
| Birkemeyer Elaine M. | Chief Financial Officer | S Sale | 2024-05-16 | 2024-05-20 | 3,041 | $13.68 | $41.6K | 61,295 | SEC↗ |
| Washington Boyd Vindell | Director | A Award | 2024-05-08 | 2024-05-10 | 10,469 | — | $0 | 19,169 | SEC↗ |
| Volkart Carmen B | Director | A Award | 2024-05-08 | 2024-05-10 | 10,469 | — | $0 | 21,620 | SEC↗ |
| Shafer David Brent | Director | A Award | 2024-05-08 | 2024-05-10 | 10,469 | — | $0 | 32,744 | SEC↗ |
| Huggenberger Raymond | Director | A Award | 2024-05-08 | 2024-05-10 | 10,469 | — | $0 | 40,242 | SEC↗ |
| Dodd Sheri Louise | Director | A Award | 2024-05-08 | 2024-05-10 | 10,469 | — | $0 | 33,654 | SEC↗ |
| Asbury Valerie L. | Director | A Award | 2024-05-08 | 2024-05-10 | 10,469 | — | $0 | 32,744 | SEC↗ |
| BURKE WILLIAM W | Director | S Sale | 2024-05-08 | 2024-05-10 | 2,500 | $14.06 | $35.1K | 25,273 | SEC↗ |
| BURKE WILLIAM W | Director | A Award | 2024-05-08 | 2024-05-10 | 10,469 | — | $0 | 35,742 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2024-05-06 | 2024-05-08 | 815 | $14.37 | $11.7K | 62,574 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2024-02-29 | 2024-02-29 | 1,396 | $15.25 | $21.3K | 238,027 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2024-02-29 | 2024-02-29 | 243 | $15.25 | $3.7K | 63,389 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2024-02-27 | 2024-02-29 | 4,689 | $15.60 | $73.1K | 239,423 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2024-02-27 | 2024-02-29 | 1,091 | $15.58 | $17.0K | 63,632 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2024-02-26 | 2024-02-27 | 2,015 | $15.91 | $32.1K | 63,512 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2024-02-26 | 2024-02-27 | 6,239 | $15.81 | $98.6K | 244,112 | SEC↗ |
| Birkemeyer Elaine M. | Chief Financial Officer | A Award | 2024-02-24 | 2024-02-27 | 2,848 | — | $0 | 64,336 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2024-02-24 | 2024-02-27 | 8,986 | — | $0 | 62,751 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2024-02-24 | 2024-02-27 | 2,776 | — | $0 | 65,527 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award | 2024-02-24 | 2024-02-27 | 44,930 | — | $0 | 237,251 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award | 2024-02-24 | 2024-02-27 | 13,100 | — | $0 | 250,351 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2024-02-23 | 2024-02-27 | 2,249 | $14.80 | $33.3K | 53,765 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2024-02-23 | 2024-02-27 | 5,378 | $14.85 | $79.9K | 192,321 | SEC↗ |
| Birkemeyer Elaine M. | Chief Financial Officer | A Award | 2024-02-21 | 2024-02-23 | 32,420 | — | $0 | 61,488 | SEC↗ |
| Ferstler Sherri Lee | Senior VP, Sales | A Award | 2024-02-21 | 2024-02-23 | 21,613 | — | $0 | 40,314 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2024-02-21 | 2024-02-23 | 19,452 | — | $0 | 56,014 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award | 2024-02-21 | 2024-02-23 | 72,046 | — | $0 | 197,699 | SEC↗ |
| Washington Boyd Vindell | Director | A Award | 2023-11-08 | 2023-11-13 | 8,700 | — | $0 | 8,700 | SEC↗ |
| Ferstler Sherri Lee | Senior VP, Sales | A Award | 2023-08-09 | 2023-08-11 | 18,701 | — | $0 | 18,701 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2023-08-07 | 2023-08-09 | 1,062 | $20.53 | $21.8K | 125,653 | SEC↗ |
| BURKE WILLIAM W | Director | S Sale | 2023-05-12 | 2023-05-16 | 4,400 | $21.86 | $96.2K | 27,773 | SEC↗ |
| Birkemeyer Elaine M. | Chief Financial Officer | A Award | 2023-05-10 | 2023-05-11 | 29,068 | — | $0 | 29,068 | SEC↗ |
| PAULS ERIC | Senior VP, Sales | S Sale | 2023-05-08 | 2023-05-10 | 550 | $18.55 | $10.2K | 29,498 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2023-05-08 | 2023-05-10 | 786 | $18.65 | $14.7K | 36,562 | SEC↗ |
| Volkart Carmen B | Director | A Award | 2023-05-08 | 2023-05-10 | 7,737 | — | $0 | 11,151 | SEC↗ |
| Shafer David Brent | Director | A Award | 2023-05-08 | 2023-05-10 | 7,737 | — | $0 | 22,275 | SEC↗ |
| Huggenberger Raymond | Director | A Award | 2023-05-08 | 2023-05-10 | 7,737 | — | $0 | 29,773 | SEC↗ |
| Dodd Sheri Louise | Director | A Award | 2023-05-08 | 2023-05-10 | 7,737 | — | $0 | 23,185 | SEC↗ |
| BURKE WILLIAM W | Director | A Award | 2023-05-08 | 2023-05-10 | 7,737 | — | $0 | 32,173 | SEC↗ |
| Asbury Valerie L. | Director | A Award | 2023-05-08 | 2023-05-10 | 7,737 | — | $0 | 22,275 | SEC↗ |
| Moen Brent | Chief Financial Officer | S Sale | 2023-03-01 | 2023-03-03 | 1,391 | $14.10 | $19.6K | 48,760 | SEC↗ |
| PAULS ERIC | Senior VP, Sales | S Sale | 2023-02-28 | 2023-02-28 | 72 | $14.54 | $1.0K | 30,048 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2023-02-28 | 2023-02-28 | 135 | $14.58 | $2.0K | 37,348 | SEC↗ |
| Moen Brent | Chief Financial Officer | S Sale | 2023-02-28 | 2023-02-28 | 251 | $14.58 | $3.7K | 50,151 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2023-02-28 | 2023-02-28 | 700 | $14.56 | $10.2K | 126,715 | SEC↗ |
| PAULS ERIC | Senior VP, Sales | S Sale | 2023-02-27 | 2023-02-28 | 1,401 | $15.33 | $21.5K | 30,120 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2023-02-27 | 2023-02-28 | 2,162 | $15.39 | $33.3K | 37,483 | SEC↗ |
| Moen Brent | Chief Financial Officer | S Sale | 2023-02-27 | 2023-02-28 | 3,801 | $15.36 | $58.4K | 50,402 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2023-02-27 | 2023-02-28 | 6,387 | $15.27 | $97.5K | 127,415 | SEC↗ |
| PAULS ERIC | Senior VP, Sales | A Award | 2023-02-25 | 2023-02-28 | 595 | — | $0 | 31,521 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2023-02-25 | 2023-02-28 | 962 | — | $0 | 39,645 | SEC↗ |
| Moen Brent | Chief Financial Officer | A Award | 2023-02-25 | 2023-02-28 | 2,304 | — | $0 | 54,203 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award | 2023-02-25 | 2023-02-28 | 6,482 | — | $0 | 133,802 | SEC↗ |
| PAULS ERIC | Senior VP, Sales | A Award | 2023-02-22 | 2023-02-24 | 12,627 | — | $0 | 30,926 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2023-02-22 | 2023-02-24 | 16,724 | — | $0 | 38,683 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award | 2023-02-22 | 2023-02-24 | 52,613 | — | $0 | 127,320 | SEC↗ |
| Volkart Carmen B | Director | A Award | 2023-02-22 | 2023-02-24 | 3,414 | — | $0 | 3,414 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2022-08-08 | 2022-08-10 | 1,020 | $9.18 | $9.4K | 74,707 | SEC↗ |
| BURKE WILLIAM W | Director | P Buy | 2022-08-04 | 2022-08-08 | 4,900 | $9.15 | $44.8K | 24,436 | SEC↗ |
| BURKE WILLIAM W | Director | S Sale | 2022-05-19 | 2022-05-23 | 1,100 | $10.12 | $11.1K | 19,536 | SEC↗ |
| Huggenberger Raymond | Director | A Award | 2022-05-09 | 2022-05-11 | 12,103 | — | $0 | 22,036 | SEC↗ |
| Jain Deepti | Director | A Award | 2022-05-09 | 2022-05-11 | 12,103 | — | $0 | 15,448 | SEC↗ |
| Dodd Sheri Louise | Director | A Award | 2022-05-09 | 2022-05-11 | 12,103 | — | $0 | 15,448 | SEC↗ |
| BURKE WILLIAM W | Director | A Award | 2022-05-09 | 2022-05-11 | 12,103 | — | $0 | 20,636 | SEC↗ |
| Shafer David Brent | Director | A Award | 2022-05-09 | 2022-05-11 | 12,103 | — | $0 | 14,538 | SEC↗ |
| Asbury Valerie L. | Director | A Award | 2022-05-09 | 2022-05-11 | 12,103 | — | $0 | 14,538 | SEC↗ |
| PAULS ERIC | Senior VP, Sales | S Sale | 2022-05-06 | 2022-05-10 | 600 | $13.03 | $7.8K | 18,299 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | S Sale | 2022-05-06 | 2022-05-10 | 999 | $13.04 | $13.0K | 21,959 | SEC↗ |
| Moen Brent | Chief Financial Officer | S Sale | 2022-03-07 | 2022-03-09 | 176 | $20.64 | $3.6K | 51,899 | SEC↗ |
| Moen Brent | Chief Financial Officer | S Sale | 2022-03-01 | 2022-03-03 | 1,632 | $20.33 | $33.2K | 52,075 | SEC↗ |
| Moen Brent | Chief Financial Officer | S Sale | 2022-02-28 | 2022-02-28 | 624 | $19.85 | $12.4K | 53,707 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2022-02-28 | 2022-02-28 | 877 | $19.78 | $17.3K | 75,727 | SEC↗ |
| Shafer David Brent | Director | A Award | 2022-02-24 | 2022-02-28 | 2,435 | — | $0 | 2,435 | SEC↗ |
| Asbury Valerie L. | Director | A Award | 2022-02-24 | 2022-02-28 | 2,435 | — | $0 | 2,435 | SEC↗ |
| PAULS ERIC | Senior VP, Sales | A Award | 2022-02-24 | 2022-02-28 | 12,944 | — | $0 | 18,899 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2022-02-24 | 2022-02-28 | 16,181 | — | $0 | 22,958 | SEC↗ |
| Moen Brent | Chief Financial Officer | A Award | 2022-02-24 | 2022-02-28 | 29,126 | — | $0 | 54,331 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award | 2022-02-24 | 2022-02-28 | 53,937 | — | $0 | 76,604 | SEC↗ |
| ROCHE KEVIN H | Director | M Exercise deriv | 2021-10-01 | 2021-10-05 | 6,391 | — | $0 | 0 | SEC↗ |
| ROCHE KEVIN H | Director | M Exercise deriv | 2021-10-01 | 2021-10-05 | 14,370 | — | $0 | 0 | SEC↗ |
| ROCHE KEVIN H | Director | M Exercise deriv | 2021-10-01 | 2021-10-05 | 4,994 | — | $0 | 0 | SEC↗ |
| ROCHE KEVIN H | Director | M Exercise | 2021-10-01 | 2021-10-05 | 4,994 | $0.68 | $3.4K | 45,467 | SEC↗ |
| ROCHE KEVIN H | Director | M Exercise | 2021-10-01 | 2021-10-05 | 14,370 | $10.00 | $143.7K | 59,837 | SEC↗ |
| ROCHE KEVIN H | Director | M Exercise | 2021-10-01 | 2021-10-05 | 6,391 | $21.68 | $138.6K | 66,228 | SEC↗ |
| Moen Brent | Chief Financial Officer | F Tax w/h | 2021-09-02 | 2021-09-07 | 486 | $44.87 | $21.8K | 25,205 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2021-08-06 | 2021-08-09 | 1,063 | $43.11 | $45.8K | 22,667 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | S Sale | 2021-07-07 | 2021-07-07 | 2,961 | $49.75 | $147.3K | 23,730 | SEC↗ |
| BURKE WILLIAM W | Director | M Exercise deriv | 2021-06-24 | 2021-06-28 | 0 | — | $0 | 0 | SEC↗ |
| BURKE WILLIAM W | Director | M Exercise deriv | 2021-06-24 | 2021-06-28 | 1,370 | — | $0 | 0 | SEC↗ |
| BURKE WILLIAM W | Director | M Exercise | 2021-06-24 | 2021-06-28 | 1,370 | $10.00 | $13.7K | 15,294 | SEC↗ |
| BURKE WILLIAM W | Director | M Exercise | 2021-06-24 | 2021-06-28 | 6,391 | $21.68 | $138.6K | 13,924 | SEC↗ |
| BURKE WILLIAM W | Director | S Sale | 2021-06-24 | 2021-06-28 | 6,761 | $55.00 | $371.9K | 8,533 | SEC↗ |
| Huggenberger Raymond | Director | A Award | 2021-05-17 | 2021-05-19 | 2,490 | — | $0 | 9,933 | SEC↗ |
| Jain Deepti | Director | A Award | 2021-05-17 | 2021-05-19 | 2,490 | — | $0 | 3,345 | SEC↗ |
| Dodd Sheri Louise | Director | A Award | 2021-05-17 | 2021-05-19 | 2,490 | — | $0 | 3,345 | SEC↗ |
| ROCHE KEVIN H | Director | A Award | 2021-05-17 | 2021-05-19 | 2,490 | — | $0 | 40,473 | SEC↗ |
| NIGON RICHARD | Director | A Award | 2021-05-17 | 2021-05-19 | 2,490 | — | $0 | 21,131 | SEC↗ |
| BURKE WILLIAM W | Director | A Award | 2021-05-17 | 2021-05-19 | 2,490 | — | $0 | 7,533 | SEC↗ |
| SODERBERG PETER H | Director | A Award | 2021-05-17 | 2021-05-19 | 2,490 | — | $0 | 7,844 | SEC↗ |
| BURKE WILLIAM W | Director | S Sale | 2021-05-13 | 2021-05-17 | 800 | $52.08 | $41.7K | 5,043 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award deriv | 2021-05-05 | 2021-05-07 | 5,094 | — | $0 | 5,094 | SEC↗ |
| PAULS ERIC | Senior VP, Sales | A Award deriv | 2021-05-05 | 2021-05-07 | 3,153 | — | $0 | 3,153 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2021-05-05 | 2021-05-07 | 4,621 | — | $0 | 6,777 | SEC↗ |
| Burns Kristie | Sr. VP Mktg & Clinical Affai | A Award | 2021-05-05 | 2021-05-07 | 2,156 | — | $0 | 2,156 | SEC↗ |
| PAULS ERIC | Senior VP, Sales | A Award | 2021-05-05 | 2021-05-07 | 1,334 | — | $0 | 1,334 | SEC↗ |
| PAULS ERIC | Senior VP, Sales | A Award | 2021-05-05 | 2021-05-07 | 4,621 | — | $0 | 5,955 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2021-03-05 | 2021-03-09 | 196 | $47.15 | $9.2K | 37,567 | SEC↗ |
| Moen Brent | Chief Financial Officer | S Sale | 2021-03-05 | 2021-03-09 | 174 | $47.33 | $8.2K | 25,691 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2021-02-28 | 2021-03-02 | 1,062 | $50.90 | $54.1K | 37,763 | SEC↗ |
| Moen Brent | Chief Financial Officer | S Sale | 2021-02-28 | 2021-03-02 | 1,429 | $50.91 | $72.8K | 25,865 | SEC↗ |
| Rishe Bryan | SVP, Sales | F Tax w/h | 2021-02-26 | 2021-03-02 | 2,341 | $54.12 | $126.7K | 38,825 | SEC↗ |
| Moen Brent | Chief Financial Officer | F Tax w/h | 2021-02-26 | 2021-03-02 | 826 | $54.12 | $44.7K | 27,294 | SEC↗ |
| Rishe Bryan | SVP, Sales | A Award deriv | 2021-02-25 | 2021-03-02 | 6,053 | — | $0 | 6,053 | SEC↗ |
| Moen Brent | Chief Financial Officer | A Award deriv | 2021-02-25 | 2021-03-02 | 13,835 | — | $0 | 13,835 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award deriv | 2021-02-25 | 2021-03-02 | 19,456 | — | $0 | 19,456 | SEC↗ |
| Jain Deepti | Director | A Award | 2021-02-25 | 2021-03-01 | 855 | — | $0 | 855 | SEC↗ |
| Dodd Sheri Louise | Director | A Award | 2021-02-25 | 2021-03-01 | 855 | — | $0 | 855 | SEC↗ |
| Rishe Bryan | SVP, Sales | A Award | 2021-02-25 | 2021-03-02 | 2,260 | — | $0 | 41,166 | SEC↗ |
| Moen Brent | Chief Financial Officer | A Award | 2021-02-25 | 2021-03-02 | 5,167 | — | $0 | 28,120 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award | 2021-02-25 | 2021-03-02 | 7,267 | — | $0 | 26,691 | SEC↗ |
| BURKE WILLIAM W | Director | M Exercise deriv | 2021-01-04 | 2021-01-06 | 1,500 | — | $0 | 1,370 | SEC↗ |
| BURKE WILLIAM W | Director | S Sale | 2021-01-04 | 2021-01-06 | 1,500 | $45.13 | $67.7K | 5,843 | SEC↗ |
| BURKE WILLIAM W | Director | M Exercise | 2021-01-04 | 2021-01-06 | 1,500 | $10.00 | $15.0K | 7,343 | SEC↗ |
| SODERBERG PETER H | Director | A Award | 2020-12-31 | 2021-01-05 | 250 | $44.94 | $11.2K | 5,354 | SEC↗ |
| BURKE WILLIAM W | Director | M Exercise deriv | 2020-11-02 | 2020-11-04 | 1,500 | — | $0 | 2,870 | SEC↗ |
| BURKE WILLIAM W | Director | M Exercise | 2020-11-02 | 2020-11-04 | 1,500 | $10.00 | $15.0K | 7,343 | SEC↗ |
| BURKE WILLIAM W | Director | S Sale | 2020-11-02 | 2020-11-04 | 1,500 | $37.50 | $56.3K | 5,843 | SEC↗ |
| SODERBERG PETER H | Director | A Award | 2020-09-30 | 2020-10-02 | 307 | $36.59 | $11.2K | 5,104 | SEC↗ |
| Moen Brent | Chief Financial Officer | F Tax w/h | 2020-09-02 | 2020-09-11 | 486 | $36.94 | $18.0K | 22,953 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award deriv | 2020-08-05 | 2020-08-07 | 24,818 | — | $0 | 24,818 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award deriv | 2020-08-05 | 2020-08-07 | 26,210 | — | $0 | 26,210 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award | 2020-08-05 | 2020-08-07 | 10,178 | — | $0 | 10,178 | SEC↗ |
| REUVERS DANIEL L. | President and CEO | A Award | 2020-08-05 | 2020-08-07 | 9,246 | — | $0 | 19,424 | SEC↗ |
| SODERBERG PETER H | Director | A Award | 2020-06-30 | 2020-07-02 | 271 | $41.43 | $11.2K | 4,797 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-06-25 | 2020-06-29 | 2,331 | $40.66 | $94.8K | 38,906 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-06-10 | 2020-06-12 | 2,330 | $44.77 | $104.3K | 41,237 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-05-26 | 2020-05-28 | 2,330 | $50.10 | $116.7K | 43,567 | SEC↗ |
| BURKE WILLIAM W | Director | S Sale | 2020-05-13 | 2020-05-15 | 550 | $49.94 | $27.5K | 5,843 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-05-11 | 2020-05-13 | 2,330 | $49.22 | $114.7K | 45,448 | SEC↗ |
| SODERBERG PETER H | Director | A Award | 2020-05-04 | 2020-05-06 | 2,672 | — | $0 | 6,680 | SEC↗ |
| Huggenberger Raymond | Director | A Award | 2020-05-04 | 2020-05-06 | 2,672 | — | $0 | 7,443 | SEC↗ |
| Pegus Cheryl | Director | A Award | 2020-05-04 | 2020-05-06 | 2,672 | — | $0 | 9,131 | SEC↗ |
| ROCHE KEVIN H | Director | A Award | 2020-05-04 | 2020-05-06 | 2,672 | — | $0 | 37,983 | SEC↗ |
| NIGON RICHARD | Director | A Award | 2020-05-04 | 2020-05-06 | 2,672 | — | $0 | 18,641 | SEC↗ |
| BURKE WILLIAM W | Director | A Award | 2020-05-04 | 2020-05-06 | 2,672 | — | $0 | 6,393 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | M Exercise deriv | 2020-04-29 | 2020-04-30 | 93,002 | — | $0 | 0 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | S Sale | 2020-04-29 | 2020-04-30 | 28,115 | $55.48 | $1.56M | 243,569 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | S Sale | 2020-04-29 | 2020-04-30 | 11,785 | $56.14 | $661.6K | 231,784 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | M Exercise | 2020-04-29 | 2020-04-30 | 93,002 | $0.96 | $89.3K | 324,786 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | S Sale | 2020-04-28 | 2020-04-30 | 100 | $54.95 | $5.5K | 271,684 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-04-27 | 2020-04-29 | 2,330 | $52.66 | $122.7K | 47,778 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-04-13 | 2020-04-15 | 2,330 | $47.26 | $110.1K | 50,108 | SEC↗ |
| SODERBERG PETER H | Director | A Award | 2020-03-31 | 2020-04-02 | 280 | $40.16 | $11.2K | 12,687 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-03-25 | 2020-03-27 | 2,331 | $40.00 | $93.2K | 52,438 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-03-10 | 2020-03-12 | 2,330 | $43.75 | $101.9K | 55,188 | SEC↗ |
| Moen Brent | Chief Financial Officer | S Sale | 2020-03-05 | 2020-03-09 | 175 | $48.64 | $8.5K | 23,897 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-03-05 | 2020-03-09 | 204 | $48.87 | $10.0K | 57,518 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | S Sale | 2020-03-05 | 2020-03-09 | 560 | $48.49 | $27.2K | 272,615 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2020-03-05 | 2020-03-09 | 180 | $48.67 | $8.8K | 76,303 | SEC↗ |
| Rishe Bryan | SVP, Sales | A Award deriv | 2020-02-28 | 2020-03-03 | 7,151 | — | $0 | 7,151 | SEC↗ |
| Moen Brent | Chief Financial Officer | A Award deriv | 2020-02-28 | 2020-03-03 | 14,303 | — | $0 | 14,303 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | A Award deriv | 2020-02-28 | 2020-03-03 | 7,151 | — | $0 | 7,151 | SEC↗ |
| Rishe Bryan | SVP, Sales | A Award | 2020-02-28 | 2020-03-03 | 10,579 | — | $0 | 57,722 | SEC↗ |
| Moen Brent | Chief Financial Officer | A Award | 2020-02-28 | 2020-03-03 | 13,224 | — | $0 | 24,072 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | A Award | 2020-02-28 | 2020-03-03 | 10,579 | — | $0 | 76,483 | SEC↗ |
| Rishe Bryan | SVP, Sales | F Tax w/h | 2020-02-28 | 2020-03-13 | 460 | $50.41 | $23.2K | 54,769 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | F Tax w/h | 2020-02-28 | 2020-03-13 | 826 | $50.41 | $41.6K | 271,784 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | F Tax w/h | 2020-02-28 | 2020-03-13 | 315 | $50.41 | $15.9K | 76,032 | SEC↗ |
| Rishe Bryan | SVP, Sales | F Tax w/h | 2020-02-26 | 2020-02-28 | 1,218 | $54.12 | $65.9K | 47,143 | SEC↗ |
| Rishe Bryan | SVP, Sales | A Award | 2020-02-26 | 2020-02-28 | 11,820 | — | $0 | 48,361 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | A Award | 2020-02-26 | 2020-02-28 | 7,880 | — | $0 | 66,780 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | F Tax w/h | 2020-02-26 | 2020-02-28 | 876 | $54.12 | $47.4K | 65,904 | SEC↗ |
| Moen Brent | Chief Financial Officer | A Award | 2020-02-26 | 2020-02-28 | 4,047 | — | $0 | 11,361 | SEC↗ |
| Moen Brent | Chief Financial Officer | F Tax w/h | 2020-02-26 | 2020-02-28 | 513 | $54.12 | $27.8K | 10,848 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | F Tax w/h | 2020-02-26 | 2020-02-28 | 2,360 | $54.12 | $127.7K | 273,175 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | A Award | 2020-02-26 | 2020-02-28 | 23,177 | — | $0 | 275,535 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-02-25 | 2020-02-27 | 2,330 | $55.75 | $129.9K | 36,541 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2020-02-20 | 2020-02-24 | 2,106 | $63.62 | $134.0K | 58,900 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-02-10 | 2020-02-12 | 2,330 | $58.63 | $136.6K | 38,871 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2020-02-06 | 2020-02-10 | 2,106 | $59.17 | $124.6K | 61,006 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-01-24 | 2020-01-28 | 2,330 | $58.19 | $135.6K | 41,201 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2020-01-23 | 2020-01-27 | 2,106 | $57.21 | $120.5K | 63,112 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2020-01-10 | 2020-01-14 | 2,331 | $68.77 | $160.3K | 43,531 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2020-01-09 | 2020-01-13 | 2,106 | $68.02 | $143.3K | 65,218 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | M Exercise deriv | 2019-12-31 | 2020-01-03 | 25,000 | — | $0 | 93,002 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | M Exercise | 2019-12-31 | 2020-01-03 | 25,000 | $0.96 | $24.0K | 252,358 | SEC↗ |
| SODERBERG PETER H | Director | A Award | 2019-12-31 | 2020-01-03 | 148 | $67.51 | $10.0K | 12,407 | SEC↗ |
| Pegus Cheryl | Director | A Award | 2019-12-31 | 2020-01-03 | 148 | $67.51 | $10.0K | 6,459 | SEC↗ |
| NIGON RICHARD | Director | A Award | 2019-12-31 | 2020-01-03 | 148 | $67.51 | $10.0K | 15,969 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise deriv | 2019-12-26 | 2019-12-26 | 4,812 | — | $0 | 0 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-12-26 | 2019-12-26 | 305 | $70.81 | $21.6K | 45,862 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise | 2019-12-26 | 2019-12-26 | 4,812 | $0.96 | $4.6K | 50,674 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-12-26 | 2019-12-26 | 3,980 | $69.09 | $275.0K | 46,694 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-12-26 | 2019-12-26 | 527 | $70.04 | $36.9K | 46,167 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2019-12-26 | 2019-12-27 | 127 | $71.04 | $9.0K | 67,324 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2019-12-26 | 2019-12-27 | 500 | $70.40 | $35.2K | 67,451 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2019-12-26 | 2019-12-27 | 1,479 | $69.30 | $102.5K | 67,951 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise deriv | 2019-12-23 | 2019-12-26 | 3,409 | — | $0 | 6,819 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | S Sale | 2019-12-23 | 2019-12-26 | 30,000 | $69.85 | $2.10M | 227,358 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise | 2019-12-23 | 2019-12-26 | 3,409 | $32.36 | $110.3K | 49,271 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-12-23 | 2019-12-26 | 3,409 | $70.00 | $238.6K | 45,862 | SEC↗ |
| Mattys Gerald R. | Chief Executive Officer | G Gift | 2019-12-19 | 2019-12-23 | 4,760 | — | $0 | 257,358 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2019-12-12 | 2019-12-16 | 2,106 | $65.04 | $137.0K | 69,430 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise deriv | 2019-12-10 | 2019-12-12 | 4,813 | — | $0 | 4,812 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-12-10 | 2019-12-12 | 4,813 | $64.23 | $309.1K | 45,862 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise | 2019-12-10 | 2019-12-12 | 4,813 | $0.96 | $4.6K | 50,675 | SEC↗ |
| NIGON RICHARD | Director | G Gift | 2019-12-09 | 2020-01-03 | 1,200 | — | $0 | 15,821 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise deriv | 2019-11-25 | 2019-11-27 | 4,812 | — | $0 | 9,625 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise | 2019-11-25 | 2019-11-27 | 4,812 | $0.96 | $4.6K | 50,674 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-11-25 | 2019-11-27 | 3,655 | $61.80 | $225.9K | 47,019 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-11-25 | 2019-11-27 | 1,157 | $62.05 | $71.8K | 45,862 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | M Exercise deriv | 2019-11-22 | 2019-11-25 | 2,273 | — | $0 | 4,546 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2019-11-22 | 2019-11-25 | 2,273 | $60.12 | $136.7K | 71,536 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | M Exercise | 2019-11-22 | 2019-11-25 | 2,273 | $32.36 | $73.6K | 73,809 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2019-11-21 | 2019-11-25 | 2,106 | $58.21 | $122.6K | 71,536 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise deriv | 2019-11-11 | 2019-11-13 | 4,813 | — | $0 | 14,437 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise | 2019-11-11 | 2019-11-13 | 4,813 | $0.96 | $4.6K | 50,675 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-11-11 | 2019-11-13 | 2,100 | $51.24 | $107.6K | 48,575 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-11-11 | 2019-11-13 | 2,713 | $51.75 | $140.4K | 45,862 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2019-11-07 | 2019-11-12 | 2,106 | $51.27 | $108.0K | 73,642 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise deriv | 2019-10-25 | 2019-10-29 | 4,812 | — | $0 | 19,250 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-10-25 | 2019-10-29 | 4,812 | $44.88 | $216.0K | 45,862 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise | 2019-10-25 | 2019-10-29 | 4,812 | $0.96 | $4.6K | 50,674 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2019-10-24 | 2019-10-28 | 2,106 | $45.38 | $95.6K | 75,748 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise deriv | 2019-10-10 | 2019-10-15 | 4,813 | — | $0 | 24,062 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-10-10 | 2019-10-15 | 4,612 | $42.62 | $196.6K | 46,063 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise | 2019-10-10 | 2019-10-15 | 4,813 | $0.96 | $4.6K | 50,675 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-10-10 | 2019-10-15 | 201 | $43.19 | $8.7K | 45,862 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2019-10-10 | 2019-10-15 | 2,106 | $42.29 | $89.1K | 77,854 | SEC↗ |
| Pegus Cheryl | Director | A Award | 2019-09-30 | 2019-10-02 | 236 | $42.32 | $10.0K | 6,311 | SEC↗ |
| SODERBERG PETER H | Director | A Award | 2019-09-30 | 2019-10-02 | 236 | $42.32 | $10.0K | 12,259 | SEC↗ |
| NIGON RICHARD | Director | A Award | 2019-09-30 | 2019-10-02 | 236 | $42.32 | $10.0K | 17,021 | SEC↗ |
| Folkes Robert J. | Chief Operating Officer | S Sale | 2019-09-26 | 2019-09-30 | 2,106 | $45.11 | $95.0K | 79,960 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise deriv | 2019-09-25 | 2019-09-27 | 1,773 | — | $0 | 0 | SEC↗ |
| Rishe Bryan | SVP, Sales | M Exercise deriv | 2019-09-25 | 2019-09-27 | 3,039 | — | $0 | 28,875 | SEC↗ |
| Rishe Bryan | SVP, Sales | S Sale | 2019-09-25 | 2019-09-27 | 4,512 | $45.77 | $206.5K | 46,162 | SEC↗ |